Cholesterol-enriched diet causes age-related macular degeneration-like pathology in rabbit retina

BMC Ophthalmology

Volumn 11, Issue 1, 2011, Pages

  Dasari, Bhanu ^a   Prasanthi, Jaya Rp ^a   Marwarha, Gurdeep ^a   Singh, Brij B ^b   Ghribi, Othman ^a  

^a UNIVERSITY OF NORTH DAKOTA   (United States)

^b UNIVERSITY OF NORTH DAKOTA SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; CHOLESTEROL; REACTIVE OXYGEN METABOLITE;

ANIMAL; APOPTOSIS; ARTICLE; CHOLESTEROL INTAKE; COMPARATIVE STUDY; DISEASE COURSE; DISEASE MODEL; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; OXIDATIVE STRESS; PATHOLOGY; PROGNOSIS; RABBIT; RETINA; RETINA MACULA DEGENERATION; SPECTROPHOTOMETRY; WESTERN BLOTTING;

AMYLOID BETA-PEPTIDES; ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CHOLESTEROL; CHOLESTEROL, DIETARY; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; IMMUNOHISTOCHEMISTRY; MACULAR DEGENERATION; MALE; OXIDATIVE STRESS; PROGNOSIS; RABBITS; REACTIVE OXYGEN SPECIES; RETINA; SPECTROPHOTOMETRY;

EID: 80051795545     PISSN: None     EISSN: 14712415     Source Type: Journal    
DOI: 10.1186/1471-2415-11-22     Document Type: Article

References (85)

1. Council Lecture. Drusen and their relationship to senile macular degeneration. Sarks SH, Aust J Ophthalmol 1980 8 117 130 10.1111/j.1442-9071. 1980.tb01670.x 6160841 (Pubitemid 10014380)
2. Age-related macular degeneration histopathologic studies. The 1992 Lorenz E. Zimmerman Lecture. Green WR, Enger C, Ophthalmology 1993 100 1519 1535 7692366 (Pubitemid 23292863)
3. Basal deposits and drusen in eyes with age-related maculopathy: evidence for solid lipid particles. Curcio CA, Presley JB, Millican CL, Medeiros NE, Exp Eye Res 2005 80 761 775 10.1016/j.exer.2004.09.017 15939032 (Pubitemid 40798041)
4. Molecular pathology of age-related macular degeneration. Ding X, Patel M, Chan CC, Progress in Retinal and Eye Research 2009 28 1 18 10.1016/j. preteyeres.2008.10.001 19026761
5. Amyloid beta-peptide and amyloid pathology are central to the oxidative stress and inflammatory cascades under which Alzheimer's disease brain exists. Butterfield DA, Griffin S, Munch G, Pasinetti GM, J Alzheimers Dis 2002 4 193 201 12226538 (Pubitemid 35006051)
6. Age-Related Macular Degeneration (AMD): Alzheimer's Disease in the Eye? Kaarniranta K, Salminen A, Haapasalo A, Soininen H, Hiltunen M, J Alzheimers Dis 2011
7. Amyloid-beta is found in drusen from some age-related macular degeneration retinas, but not in drusen from normal retinas. Dentchev T, Milam AH, Lee VM, Trojanowski JQ, Dunaief JL, Mol Vis 2003 9 184 190 12764254 (Pubitemid 38097585)
8. The Alzheimer's A-peptide is deposited at sites of complement activation in pathologic deposits associated with aging and age-related macular degeneration. Johnson LV, Leitner WP, Rivest AJ, Staples MK, Radeke MJ, Anderson DH, Proceedings of the National Academy of Sciences of the United States of America 2002 99 11830 11835 10.1073/pnas.192203399 12189211 (Pubitemid 34994484)
9. Drusen deposits associated with aging and age-related macular degeneration contain nonfibrillar amyloid oligomers. Luibl V, Isas JM, Kayed R, Glabe CG, Langen R, Chen J, J Clin Invest 2006 116 378 385 10.1172/JCI25843 16453022 (Pubitemid 43228354)
10. Apolipoprotein E allele-dependent pathogenesis: a model for age-related retinal degeneration. Malek G, Johnson LV, Mace BE, Saloupis P, Schmechel DE, Rickman DW, Toth CA, Sullivan PM, Rickman CB, Proc Natl Acad Sci USA 2005 102 11900 11905 10.1073/pnas.0503015102 16079201 (Pubitemid 41170822)
11. Targeting age-related macular degeneration with Alzheimer's disease based immunotherapies: anti-amyloid-beta antibody attenuates pathologies in an age-related macular degeneration mouse model. Ding JD, Lin J, Mace BE, Herrmann R, Sullivan P, Bowes RC, Vision Res 2008 48 339 345 10.1016/j.visres.2007.07.025 17888483 (Pubitemid 351179512)
12. Alzheimer's disease and retinal neurodegeneration. Guo L, Duggan J, Cordeiro MF, Curr Alzheimer Res 2010 7 3 14 10.2174/156720510790274491 20205667
13. Assessment of visual impairment in patients with Alzheimer's disease. Sadun AA, Borchert M, DeVita E, Hinton DR, Bassi CJ, Am J Ophthalmol 1987 104 113 120 3618708 (Pubitemid 17119032)
14. Optic-nerve degeneration in Alzheimer's disease. Hinton DR, Sadun AA, Blanks JC, Miller CA, N Engl J Med 1986 315 485 487 10.1056/NEJM198608213150804 3736630 (Pubitemid 16034149)
15. Parallel findings in age-related macular degeneration and Alzheimer's disease. Ohno-Matsui K, Progress in Retinal and Eye Research 2011 30 217 238 10.1016/j.preteyeres.2011.02.004 21440663
16. Midlife Serum Cholesterol and Increased Risk of Alzheimer's and Vascular Dementia Three Decades Later. Solomon A, Kivipelto M, Wolozin B, Zhou J, Whitmer RA, Dementia and Geriatric Cognitive Disorders 2009 28 75 80 10.1159/000231980 19648749
17. Dietary fat and age-related maculopathy. Mares-Perlman JA, Brady WE, Klein R, VandenLangenberg GM, Klein BE, Palta M, Arch Ophthalmol 1995 113 743 748 7786215
18. Esterified cholesterol is highly localized to Bruch's membrane, as revealed by lipid histochemistry in wholemounts of human choroid. Rudolf M, Curcio CA, J Histochem Cytochem 2009 57 731 739 10.1369/jhc.2009.953448 19365091
19. Esterified and unesterified cholesterol in drusen and basal deposits of eyes with age-related maculopathy. Curcio CA, Presley JB, Malek G, Medeiros NE, Avery DV, Kruth HS, Exp Eye Res 2005 81 731 741 10.1016/j.exer.2005.04.012 16005869 (Pubitemid 41790421)
20. Distribution and composition of esterified and unesterified cholesterol in extra-macular drusen. Li CM, Clark ME, Rudolf M, Curcio CA, Exp Eye Res 2007 85 192 201 10.1016/j.exer.2007.04.002 17553492 (Pubitemid 47087795)
21. Histopathology of age-related macular degeneration. Green WR, Mol Vis 1999 5 27 10562651
22. Analysis of lipid deposits extracted from human macular and peripheral Bruch's membrane. Holz FG, Sheraidah G, Pauleikhoff D, Bird AC, Arch Ophthalmol 1994 112 402 406 8129668 (Pubitemid 24085153)
23. A cholesterol-enriched diet induces ultrastructural changes in retinal and macroglial rabbit cells. Trivino A, Ramirez AI, Salazar JJ, de HR, Rojas B, Padilla E, Tejerina T, Ramirez JM, Exp Eye Res 2006 83 357 366 10.1016/j.exer.2005.12.020 16580665 (Pubitemid 43850952)
24. Apolipoprotein B in cholesterol-containing drusen and basal deposits of human eyes with age-related maculopathy. Malek G, Li CM, Guidry C, Medeiros NE, Curcio CA, Am J Pathol 2003 162 413 425 10.1016/S0002-9440(10)63836-9 12547700 (Pubitemid 36267849)
25. The retinal oxysterol pathway: a unifying hypothesis for the cause of age-related macular degeneration. Javitt NB, Javitt JC, Curr Opin Ophthalmol 2009 20 151 157 10.1097/ICU.0b013e32832af468 19390436
26. Oxysterols: functional significance in fetal development and the maintenance of normal retinal function. Javitt NB, Curr Opin Lipidol 2007 18 283 288 10.1097/MOL.0b013e328133851e 17495602 (Pubitemid 46743052)
27. High cholesterol content in neurons increases BACE, beta-amyloid, and phosphorylated tau levels in rabbit hippocampus. Ghribi O, Larsen B, Schrag M, Herman MM, Exp Neurol 2006 200 460 467 10.1016/j.expneurol.2006.03.019 16696972 (Pubitemid 44107924)
28. Differential effects of 24-hydroxycholesterol and 27-hydroxycholesterol on beta-amyloid precursor protein levels and processing in human neuroblastoma SH-SY5Y cells. Prasanthi JR, Huls A, Thomasson S, Thompson A, Schommer E, Ghribi O, Mol Neurodegener 2009 4 1 10.1186/1750-1326-4-1 19126211
29. 27-hydroxycholestrol as the missing link between circulating cholesterol and AD-like pathology. Ghribi O, Schommer E, Prasanthi JRP, Alzheimer's and Dementia 2009 5 180 10.1016/j.jalz.2008.08.007 21857497
30. The oxysterol 27-hydroxycholesterol increases beta-amyloid and oxidative stress in retinal pigment epithelial cells. Dasari B, Prasanthi J, Marwarha G, Singh B, Ghribi O, BMC Ophthalmology 2010 10 22 10.1186/1471-2415-10-22 20836858
31. Extraction and Analysis of Sterols in Biological Matrices by High Performance Liquid Chromatography Electrospray Ionization Mass Spectrometry. McDonald JG, Thompson BM, McCrum EC, Russell DW, 2007 432 145 170
32. Vitronectin is a constituent of ocular drusen and the vitronectin gene is expressed in human retinal pigmented epithelial cells. Hageman GS, Mullins RF, Russell SR, Johnson LV, Anderson DH, FASEB J 1999 13 477 484 10064614 (Pubitemid 29115565)
33. Roles of CHOP/GADD153 in endoplasmic reticulum stress. Oyadomari S, Mori M, Cell Death Differ 2004 11 381 389 10.1038/sj.cdd.4401373 14685163 (Pubitemid 38489416)
34. Cholesterol oxidation in the retina: implications of 7KCh formation in chronic inflammation and age-related macular degeneration. Rodriguez IR, Larrayoz IM, J Lipid Res 2010 51 2847 2862 10.1194/jlr.R004820 20567027
35. Imaging multiple phases of neurodegeneration: a novel approach to assessing cell death in vivo. Cordeiro MF, Guo L, Coxon KM, Duggan J, Nizari S, Normando EM, Sensi SL, Sillito AM, Fitzke FW, Salt TE, Moss SE, Cell Death and Dis 2010 1 3 10.1038/cddis.2009.3
36. Relationship of Drusen and Abnormalities of the Retinal Pigment Epithelium to the Prognosis of Neovascular Macular Degeneration. Bressler SB, Maguire MG, Bressler NM, Fine SL, the Macular Photocoagulation Study Group, Arch Ophthalmol 1990 108 1442 1447 1699513 (Pubitemid 20344701)
37. Retinal Abnormalities in Early Alzheimer's Disease. Berisha F, Feke GT, Trempe CL, McMeel JW, Schepens CL, Invest Ophthalmol Vis Sci 2007 48 2285 2289 10.1167/iovs.06-1029 17460292 (Pubitemid 351261307)
38. Cholesterol at the crossroads: Alzheimer's disease and lipid metabolism. Wellington CL, Clin Genet 2004 66 1 16 10.1111/j.0009-9163.2004.00280.x 15200500 (Pubitemid 38960816)
39. Age- and region-dependent alterations in A-degrading enzymes: implications for A-induced disorders. Caccamo A, Oddo S, Sugarman MC, Akbari Y, LaFerla FM, Neurobiology of Aging 2005 26 645 654 10.1016/j.neurobiolaging.2004. 06.013 15708439 (Pubitemid 40228756)
40. Differential cerebral deposition of IDE and NEP in sporadic and familial Alzheimer's disease. Dorfman VB, Pasquini L, Riudavets M, Lopez-Costa JJ, Villegas A, Troncoso JC, Lopera F, Castano EM, Morelli L, Neurobiology of Aging 2010 31 1743 1757 10.1016/j.neurobiolaging.2008.09.016 19019493
41. Increased expression of A degrading enzyme IDE in the cortex of transgenic mice with Alzheimer's disease-like neuropathology. Vepsalainen S, Hiltunen M, Helisalmi S, Wang J, van Groen T, Tanila H, Soininen H, Neuroscience Letters 2008 438 216 220 10.1016/j.neulet.2008.04.025 18455870
42. Neprilysin and insulin-degrading enzyme levels are increased in Alzheimer disease in relation to disease severity. Miners JS, Baig S, Tayler H, Kehoe PG, Love S, J Neuropathol Exp Neurol 2009 68 902 914 10.1097/NEN.0b013e3181afe475 19606063
43. Degradation of Soluble Amyloid -Peptides 1-40, 1-42, and the Dutch Variant 1-40Q by Insulin Degrading Enzyme from Alzheimer Disease and Control Brains. Perez A, Morelli L, Cresto JC, Castano EM, Neurochemical Research 2000 25 247 255 10.1023/A:1007527721160 10786709 (Pubitemid 30210091)
44. Reduced Hippocampal Insulin-Degrading Enzyme in Late-Onset Alzheimer's Disease Is Associated with the Apolipoprotein E-4 Allele. Cook DG, Leverenz JB, McMillan PJ, Kulstad JJ, Ericksen S, Roth RA, Schellenberg GD, Jin LW, Kovacina KS, Craft S, Am J Pathol 2003 162 313 319 10.1016/S0002-9440(10)63822-9 12507914 (Pubitemid 36042013)
45. Protein oxidation in the brain in Alzheimer's disease. Aksenov MY, Aksenova MV, Butterfield DA, Geddes JW, Markesbery WR, Neuroscience 2001 103 373 383 10.1016/S0306-4522(00)00580-7 11246152 (Pubitemid 32201924)
46. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E and beta carotene for age-related cataract and vision loss: AREDS report no. 9. Arch Ophthalmol 2001 119 1439 1452 11594943
47. The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase. Tenhunen R, Marver HS, Schmid R, Proceedings of the National Academy of Sciences of the United States of America 1968 61 748 755 10.1073/pnas.61.2. 748 4386763
48. Heme oxygenase: function, multiplicity, regulatory mechanisms, and clinical applications. Maines MD, FASEB J 1988 2 2557 2568 3290025
49. "Oxidative protector" enzymes in the macular retinal pigment epithelium of aging eyes and eyes with age-related macular degeneration. Frank RN, Trans Am Ophthalmol Soc 1998 96 635 689 10360305 (Pubitemid 29012929)
50. Glial heme oxygenase-1 expression in Alzheimer disease and mild cognitive impairment. Schipper HM, Bennett DA, Liberman A, Bienias JL, Schneider JA, Kelly J, Arvanitakis Z, Neurobiol Aging 2006 27 252 261 10.1016/j. neurobiolaging.2005.01.016 16399210 (Pubitemid 43038549)
51. Heme oxygenase-1 is associated with the neurofibrillary pathology of Alzheimer's disease. Smith MA, Kutty RK, Richey PL, Yan SD, Stern D, Chader GJ, Wiggert B, Petersen RB, Perry G, Am J Pathol 1994 145 42 47 8030754 (Pubitemid 24217481)
52. Expression of heme oxygenase-1 in the senescent and Alzheimer-diseased brain. Schipper HM, Cisse S, Stopa EG, Ann Neurol 1995 37 758 768 10.1002/ana.410370609 7778849
53. Deposition of iron and beta-amyloid plaques is associated with cortical cellular damage in rabbits fed with long-term cholesterol-enriched diets. Ghribi O, Golovko MY, Larsen B, Schrag M, Murphy EJ, J Neurochem 2006 99 438 449 10.1111/j.1471-4159.2006.04079.x 17029598 (Pubitemid 44477201)
54. Evolution of geographic atrophy of the retinal pigment epithelium. Sarks JP, Sarks SH, Killingsworth MC, Eye (Lond) 1988 2 Pt 5 552 577 (Pubitemid 19142671)
55. Photoreceptor topography in ageing and age-related maculopathy. Curcio CA, Eye (Lond) 2001 15 376 383 (Pubitemid 32605667)
56. Photoreceptor loss in age-related macular degeneration. Curcio CA, Medeiros NE, Millican CL, Invest Ophthalmol Vis Sci 1996 37 1236 1249 8641827 (Pubitemid 26177300)
57. Apoptosis in human retinal degenerations. Xu GZ, Li WW, Tso MO, Trans Am Ophthalmol Soc 1996 94 411 430 8981707
58. Apoptotic photoreceptor cell death in mouse models of retinitis pigmentosa. Portera-Cailliau C, Sung CH, Nathans J, Adler R, Proceedings of the National Academy of Sciences of the United States of America 1994 91 974 978 10.1073/pnas.91.3.974 8302876 (Pubitemid 24048491)
59. Photic injury triggers apoptosis of photoreceptor cells. Abler AS, Chang CJ, Ful J, Tso MO, Lam TT, Res Commun Mol Pathol Pharmacol 1996 92 177 189 8774071 (Pubitemid 26164506)
60. Retinal ganglion cell death in experimental glaucoma and after axotomy occurs by apoptosis. Quigley HA, Nickells RW, Kerrigan LA, Pease ME, Thibault DJ, Zack DJ, Invest Ophthalmol Vis Sci 1995 36 774 786 7706025
61. TUNEL-Positive Ganglion Cells in Human Primary Open-angle Glaucoma. Kerrigan LA, Zack DJ, Quigley HA, Smith SD, Pease ME, Arch Ophthalmol 1997 115 1031 1035 9258226 (Pubitemid 27328493)
62. bcl-2 overexpression reduces apoptotic photoreceptor cell death in three different retinal degenerations. Chen J, Flannery JG, LaVail MM, Steinberg RH, Xu J, Simon MI, Proceedings of the National Academy of Sciences of the United States of America 1996 93 7042 7047 10.1073/pnas.93.14.7042 8692941 (Pubitemid 26243498)
63. Bcl-2 Facilitates Recovery from DNA Damage after Oxidative Stress. Deng G, Su JH, Ivins KJ, Van Houten B, Cotman CW, Experimental Neurology 1999 159 309 318 10.1006/exnr.1999.7145 10486199 (Pubitemid 29444927)
64. Gadd153 Sensitizes Cells to Endoplasmic Reticulum Stress by Down-Regulating Bcl2 and Perturbing the Cellular Redox State. McCullough KD, Martindale JL, Klotz LO, Aw TY, Holbrook NJ, Mol Cell Biol 2001 21 1249 1259 10.1128/MCB.21.4.1249-1259.2001 11158311 (Pubitemid 32114973)
65. Drusen proteome analysis: an approach to the etiology of age-related macular degeneration. Crabb JW, Miyagi M, Gu X, Shadrach K, West KA, Sakaguchi H, Kamei M, Hasan A, Yan L, Raybor ME, Salomon RG, Hollyfield JG, Proc Natl Acad Sci USA 2002 99 14682 14687 10.1073/pnas.222551899 12391305 (Pubitemid 35334544)
66. The Muller cell: a functional element of the retina. Newman E, Reichenbach A, Trends Neurosci 1996 19 307 312 10.1016/0166-2236(96)10040-0 8843598 (Pubitemid 26349058)
67. Control of Muller glial cell proliferation and activation following retinal injury. Dyer MA, Cepko CL, Nat Neurosci 2000 3 873 880 10.1038/78774 10966617
68. The radial glia of Muller in the rat retina and their response to injury. An immunofluorescence study with antibodies to the glial fibrillary acidic (GFA) protein. Bignami A, Dahl D, Exp Eye Res 1979 28 63 69 10.1016/0014- 4835(79)90106-4 376324 (Pubitemid 9124759)
69. Muller cells in detached human retina express glial fibrillary acidic protein and vimentin. Okada M, Matsumura M, Ogino N, Honda Y, Graefes Arch Clin Exp Ophthalmol 1990 228 467 474 10.1007/BF00927264 2227494 (Pubitemid 20291031)
70. Muller cell changes in human diabetic retinopathy. Mizutani M, Gerhardinger C, Lorenzi M, Diabetes 1998 47 445 449 10.2337/diabetes.47.3.445 9519752 (Pubitemid 28104208)
71. An immunohistochemical study of neuronal and glial cell reactions in retinae of rats with experimental glaucoma. Wang X, Tay SS, Ng YK, Exp Brain Res 2000 132 476 484 10.1007/s002210000360 10912828 (Pubitemid 30348753)
72. Muller cells in the preconditioned retinal ischemic injury rat. Nishiyama T, Nishukawa S, Hiroshi, Tomita, Tamai M, Tohoku J Exp Med 2000 191 221 232 10.1620/tjem.191.221 11038014
73. Muller cell expression of glial fibrillary acidic protein after genetic and experimental photoreceptor degeneration in the rat retina. Eisenfeld AJ, Bunt-Milam AH, Sarthy PV, Invest Ophthalmol Vis Sci 1984 25 1321 1328 6386743 (Pubitemid 15210423)
74. Intermediate filament expression in human retinal macroglia. Histopathologic changes associated with age-related macular degeneration. Madigan MC, Penfold PL, Provis JM, Balind TK, Billson FA, Retina 1994 14 65 74 8016466 (Pubitemid 24119506)
75. Changes of astrocytes in retinal ageing and age-related macular degeneration. Ramirez JM, Ramirez AI, Salazar JJ, de HR, Trivino A, Exp Eye Res 2001 73 601 615 10.1006/exer.2001.1061 11747361 (Pubitemid 34014389)
76. Phenotypic variation of retinal pigment epithelium in age-related macular degeneration. Guidry C, Medeiros NE, Curcio CA, Invest Ophthalmol Vis Sci 2002 43 267 273 11773041 (Pubitemid 34032469)
77. Role of vitronectin and its receptors in haemostasis and vascular remodeling. Preissner KT, Seiffert D, Thromb Res 1998 89 1 21 10.1016/S0049-3848(97)00298-3 9610756 (Pubitemid 28231482)
78. Genetic variants near TIMP3 and high-density lipoprotein-associated loci influence susceptibility to age-related macular degeneration. Chen W, Stambolian D, Edwards AO, Branham KE, Othman M, Jakobsdottir J, et al. Proceedings of the National Academy of Sciences 2010 107 7401 7406 10.1073/pnas.0912702107
79. Genome-wide association study of advanced age-related macular degeneration identifies a role of the hepatic lipase gene (LIPC). Neale BM, Fagerness J, Reynolds R, Sobrin L, Parker M, Raychaudhuri S, Tan PL, Oh EC, Merriam JE, Souied E, Bernstein PS, Li B, Frederick JM, Zhang K, Brantley MA Jr, Lee AY, Zack DJ, Campochiaro P, Ripke S, Smith RT, Barile GR, Katsanis N, Allikmets R, Daly MJ, Seddon M, Proceedings of the National Academy of Sciences 2010 107 7395 7400 10.1073/pnas.0912019107
80. Intraretinal lipid transport is dependent on high density lipoprotein-like particles and class B scavenger receptors. Tserentsoodol N, Gordiyenko NV, Pascual I, Lee JW, Fliesler SJ, Rodriguez IR, Mol Vis 2006 12 1319 1333 17110915 (Pubitemid 44688463)
81. Expression of reverse cholesterol transport proteins ATP-binding cassette A1 (ABCA1) and scavenger receptor BI (SR-BI) in the retina and retinal pigment epithelium. Duncan KG, Hosseini K, Bailey KR, Yang H, Lowe RJ, Matthes MT, Kane JP, LaVail MM, Schwartz DM, Duncan JL, Br J Ophthalmol 2009 93 1116 1120 10.1136/bjo.2008.144006 19304587
82. Oxysterols and neurodegenerative diseases. Bjorkhem I, Cedazo-Minguez A, Leoni V, Meaney S, Molecular Aspects of Medicine 2009 30 171 179 10.1016/j.mam.2009.02.001 19248803
83. Cholestenoic Acid is an important elimination product of cholesterol in the retina: comparison of retinal cholesterol metabolism with that in the brain. Mast N, Reem R, Bederman I, Huang S, Dipatre PL, Bjorkhem I, Pikuleva IA, Invest Ophthalmol Vis Sci 2011 52 594 603 10.1167/iovs.10-6021 20881306
84. The ins and outs of cholesterol in the vertebrate retina. Fliesler SJ, Bretillon L, Journal of Lipid Research 2010 51 3399 3413 10.1194/jlr.R010538 20861164
85. Side effects of oxysterols: cytotoxicity, oxidation, inflammation, and phospholipidosis. Vejux A, Malvitte L, Lizard G, Braz J Med Biol Res 2008 41 545 556 10.1590/S0100-879X2008000700001 18719735